临床进展临床缓解早期干预
重度哮喘早期启动生物制剂治疗:基于全球真实世界队列提升缓解率与临床转归
By MedXY|2026年9月14日
在重度哮喘中更早启动生物制剂可提高临床缓解率、减少急性加重、保护肺功能并降低糖皮质激素依赖,提示治疗策略应由“预留”转向“保留”。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.